[PDF][PDF] Preclinical and clinical perspective on fungal metabolites and their analogs as anticancer agents–from bench to bedside
S Banerjee, SB Paruthy - Fungal metabolites, 2016 - ndl.ethernet.edu.et
Emerging viewpoints from contemporary research on terrestrial fungal metabolites provides
an insight into their valuable insidious biological activity including cancer therapeutics …
an insight into their valuable insidious biological activity including cancer therapeutics …
Fungal metabolites with anticancer activity
Covering: 1964 to 2013 Natural products from bacteria and plants have played a leading
role in cancer drug discovery resulting in a large number of clinically useful agents. In …
role in cancer drug discovery resulting in a large number of clinically useful agents. In …
Fungal anticancer metabolites: synthesis towards drug discovery
M Barbero, E Artuso, C Prandi - Current medicinal chemistry, 2018 - ingentaconnect.com
Background: Fungi are a well-known and valuable source of compounds of therapeutic
relevance, in particular of novel anticancer compounds. Although seldom obtainable …
relevance, in particular of novel anticancer compounds. Although seldom obtainable …
Anticancer fungal natural products: Mechanisms of action and biosynthesis
S Yuan, JV Gopal, S Ren, L Chen, L Liu… - European Journal of …, 2020 - Elsevier
Many fungal metabolites show promising anticancer properties both in vitro and in animal
models, and some synthetic analogs of those metabolites have progressed into clinical …
models, and some synthetic analogs of those metabolites have progressed into clinical …
Toward a cancer drug of fungal origin
Although fungi produce highly structurally diverse metabolites, many of which have served
as excellent sources of pharmaceuticals, no fungi‐derived agent has been approved as a …
as excellent sources of pharmaceuticals, no fungi‐derived agent has been approved as a …
Fungal metabolites: structural diversity as incentive for anticancer drug development
H Greve, IE Mohamed, A Pontius, S Kehraus… - Phytochemistry …, 2010 - Springer
Natural products play an important role in the development of anticancer drugs. To date,
predominantly metabolites from plants and bacteria served as lead structures for anticancer …
predominantly metabolites from plants and bacteria served as lead structures for anticancer …
Fungal secondary metabolites: A promising source of antineoplastic drugs
HY Ahmed, HH El Shikh, EA Ghoneimy… - Current Cancer …, 2010 - ingentaconnect.com
The rapid progress in understanding the molecular biology of cancer has made a large
impact on the design and development of novel therapeutic strategies prompted by the multi …
impact on the design and development of novel therapeutic strategies prompted by the multi …
A promising source of anticancer drug from fungal secondary metabolite
Secondary metabolites from fungi have been purified, characterized, and further modified in
their moieties as anticancer agents. In the last few decades, fungal metabolites have …
their moieties as anticancer agents. In the last few decades, fungal metabolites have …
Antitumor metabolites of fungi
R Nicoletti, A Fiorentino - Current Bioactive Compounds, 2014 - ingentaconnect.com
The exploitation of the antitumor properties of fungal secondary metabolites is one of the
fundamental objectives pursued by a multiplicity of research groups and laboratories …
fundamental objectives pursued by a multiplicity of research groups and laboratories …
Metabolites from Fungi: A Promising Source of Lead Compounds Against Cancer
C Contigli, WP de Andrade, PG Cardoso, Y Oki… - Fungi Bioactive …, 2024 - Springer
The diversity of fungi represents a fabulous and remarkable asset of sources of bioactive
compounds with vast potential for pharmaceutical applications. Especially in Oncology …
compounds with vast potential for pharmaceutical applications. Especially in Oncology …